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Abstract
Background: Integrins are heterodimeric cell adhesion molecules, with 18 a (ITGA) and eight b (ITGB) subunits forming 24
heterodimers classified into five families. Certain integrins, especially the a4/a9 (ITGA4/ITGA9) family, interact with members
of the ADAM (a disintegrin and metalloprotease) family. ADAM2 is among the better characterized and also of interest
because of its role in sperm function. Having shown that ITGA9 on mouse eggs participates in mouse sperm-egg
interactions, we sought to characterize ITGA4/ITGA9-ADAM2 interactions.
Methodology/Principal Findings: An anti-b1/ITGB1 function-blocking antibody that reduces sperm-egg binding
significantly inhibited ADAM2 binding to mouse eggs. Analysis of integrin subunit expression indicates that mouse eggs
could express at least ten different integrins, five in the RGD-binding family, two in the laminin-binding family, two in the
collagen-binding family, and ITGA9-ITGB1. Adhesion assays to characterize ADAM2 interactions with ITGA4/ITGA9 family
members produced the surprising result that RPMI 8866 cell adhesion to ADAM2 was inhibited by an anti-ITGA9 antibody,
noteworthy because ITGA9 has only been reported to dimerize with ITGB1, and RPMI 8866 cells lack detectable ITGB1.
Antibody and siRNA studies demonstrate that ITGB7 is the b subunit contributing to RPMI 8866 adhesion to ADAM2.
Conclusions/Significance: These data indicate that a novel integrin a-b combination, ITGA9-ITGB7 (a9b7), in RPMI 8866 cells
functions as a binding partner for ADAM2. ITGA9 had previously only been reported to dimerize with ITGB1. Although
ITGA9-ITGB7 is unlikely to be a widely expressed integrin and appears to be the result of ‘‘compensatory dimerization’’
occurring in the context of little/no ITGB1 expression, the data indicate that ITGA9-ITGB7 functions as an ADAM binding
partner in certain cellular contexts, with implications for mammalian fertilization and integrin function.
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Introduction
Integrins are a family of cell adhesion molecules that mediate
cell-cell and cell-extracellular matrix interactions [1,2,3] that also
have been implicated as having a role in contributing to
mammalian sperm-egg interactions. Integrins are heterodimeric
transmembrane proteins made of an a and a b subunit, with 18 a
and eight b subunits in mammals. (Note: Traditional nomencla-
ture refers to a and b subunits; Human Genome Organization-
and Mouse Genome Database-approved nomenclature refers
these as ITGA and ITGB subunits respectively, and we will use
that terminology here. For example, a9 is ITGA9 and b1 is
ITGB1.) The 24 known heterodimer combinations are classified
into five different subfamilies based sequence homologies of the a
subunits and on ligand specificity [1,4,5]. One of the more recently
characterized groups of integrin ligands is the ADAM (a
disintegrin and metalloprotease) family of proteins, with the
adhesive activity largely mediated by the disintegrin-like domain,
so-named due to the domain’s homology to disintegrin domains in
snake venom metalloproteases that interact with integrins
[6,7,8,9].
This study examines a4/a9 (ITGA4/ITGA9) integrin interac-
tions with ADAM2 in the context of mammalian sperm-egg
interactions and also general cell adhesion. We have demonstrated
that an egg ITGA4/ITGA9 integrin functions in murine
fertilization; RNAi-mediated knockdown of Itga9 in mouse eggs
reduces sperm binding and subsequent fusion [10] and treatment
of mouse eggs with a specific peptide inhibitor of ITGA4/ITGA9
integrins reduces the binding of recombinant ADAM2 [11].
Mouse and human eggs express ITGA9 [10], and ITGA4
expression has been observed in bovine, hamster, pig, and human
eggs [12,13,14,15]. Both ITGA4 and ITGA9 dimerize with
ITGB1, and ITGA4 also dimerizes with ITGB7. ITGB1 is
expressed by eggs in numerous mammalian species [12,14,
15,16,17,18,19,20]. ITGB1 is not essential for fertilization in mice
based on studies of an oocyte-specific Itgb1 conditional knockout
[21], although Itgb1-deficient eggs do have subtle defects, as recent
studies have revealed delayed sperm binding to Itgb1-deficient eggs
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eggs treated with anti-ITGB1 antibodies [10,14,19,23].
ADAM2 is one of the ADAM family members on sperm and is
one of the best characterized ADAMs in terms of its interactions
with cells and with integrins [23,24,25,26,27]. Studies of Adam2-
null mice reveal defects in several sperm functions, including
sperm-egg binding [28,29,30,31,32]. The adhesion-mediating
motif of ADAM2 is well-conserved among the ADAMs, making
it a good ‘‘model’’ ADAM for ADAM-integrin interactions.
ADAM2 has an ECD tripeptide in the disintegrin domain that was
characterized by structure-function studies as important for
ADAM2 binding to eggs [24,25], and also has a sequence similar
to the RX6DLPEF motif in ADAM15 that is important in binding
ITGA9-ITGB1 [33] (RLAQDECDVTEY in mouse ADAM2,
RPSFEECDLPEY in human ADAM2). Additionally, three of the
seven residues in ADAM28 implicated in interaction with ITGA4-
ITGB1 [34] are conserved in ADAM2.
We sought to characterize ITGA4/ITGA9 function as an
ADAM2 binding partner through assays of ADAM2 disintegrin
domain interactions with mouse eggs and also through cell
adhesion assays with cell lines known to express each of the
ITGA4/ITGA9 integrins. As noted above, the ITGA4/ITGA9
integrin family has three known members: ITGA4-ITGB1,
ITGA4-ITGB7, and ITGA9-ITGB1. Experiments here first
examined mouse eggs, addressing the question of whether ITGB1
(as the partner to ITGA9) is the primary integrin in mouse eggs
that mediates egg interactions with ADAM2. Second, since
ITGA4 expression has been observed in bovine, hamster, pig,
and human eggs [12,13,14,15], we examined the interactions of
the ITGA4 integrins, ITGA4-ITGB1 and ITGA4-ITGB7, with
ADAM2. These experiments produced an unexpected and
intriguing result. These studies used RPMI 8866 cells, a human
B-cell lymphoblastoid cell line that is commonly used to study
ITGA4-ITGB7-mediated cell adhesion; these cells express little or
no ITGB1 on the cell surface [35,36,37,38,39]. These cell
adhesion assays demonstrated that RPMI 8866 cells adhere to
ADAM2, but a surprise came from assays using function-blocking
antibodies that revealed that this adhesion was inhibited not only
by anti-ITGA4 antibodies but also an anti-ITGA9 antibody. This
was of significant interest because ITGA9 has only been reported
to dimerize with ITGB1, and as noted, RPMI 8866 cells have low
to undetectable levels of ITGB1, in agreement with the fact that
anti-ITGB1 antibodies have no effect on RPMI 8866 adhesion to
multiple substrates, including ADAMs [36,39]. Our siRNA and
function-blocking antibody studies demonstrate that ITGB7 is the
b subunit that contributes to adhesion to ADAM2. These studies
provide new insights into ADAM-integrin interactions and into
integrin biology, suggesting the presence of a new integrin
heterodimer, ITGA9-ITGB7, in RPMI 8866 cells that can
interact with ADAM2.
Results
As noted above, our work implicates an ITGA4/ITGA9
integrin on eggs in sperm-egg adhesion [10,11]. We also have
shown that the anti-mouse ITGB1 function-blocking antibody
Hmb1-1 reduces sperm-egg binding [10], and therefore we
examined the effect of this Hmb1-1 anti-ITGB1 antibody on the
binding of ADAM2 to eggs, comparing its effects side-by-side with
the effects of two control reagents: an ECD peptide, corresponding
to the ECD-containing adhesion-mediating motif in the ADAM2
disintegrin domain [24], and an MLD peptide, a peptide that
blocks ITGA4/ITGA9 integrins [11,40,41,42]. Eggs treated with
the control reagents (point-mutated peptides ECA and MAA, for
ECD and MLD respectively; or nonimmune antibody) had levels
of ADAM2 binding that were comparable to untreated eggs
(Fig. 1). The extent of the anti-ITGB1 antibody-mediated
inhibition was similar to the extent of inhibition observed with
the positive control reagents, the ECD and MLD peptides (Fig. 1),
suggesting that ITGB1 integrins are the major integrins contrib-
uting to ADAM2 interaction with the egg plasma membrane.
To complement this, we sought a complete picture of b subunit
expression in mouse eggs; we also included examination three a
integrin subunits (Itga1/a1, Itga8/a8, Itgad/aD) whose expression
has not yet been confirmed in mouse oocytes but had been
implicated from transcriptome analyses ([43], Unigene). Although
several of these integrin subunits have been shown to have limited
tissue distribution, there is precedent for oocytes expressing a
variety of members of other molecular families that had previously
been thought to have very restricted expression [44]. This RT-
PCR analysis showed that mouse oocytes express Itgb1, Itgb3, Itgb5,
Itga1, and Itga8 (Fig. 2). No PCR products were amplified from
control oocyte cDNA preparations from which the reverse
transcriptase had been omitted, indicating that the PCR products
were amplified from cDNA (Fig. 2). We did not detect Itgb2, Itgb4,
Itgb6, Itgb7, Itgb8,o rItgad in mouse oocytes (Fig. 2), while we could
detect these transcripts in control tissues (spleen or liver as
indicated; Fig. 2).
We also sought to characterize cellular interactions with
ADAM2 in cell lines expressing the three known members of
the ITGA4/ITGA9 family (ITGA4-ITGB1, ITGA9-ITGB1,
ITGA4-ITGB7) as a complementary part of this work, since
ITGA4 expression has been reported for bovine, hamster, pig, and
human eggs, and there is some evidence for ITGB7 expression by
human eggs [12,13,14,15]. Human cell lines are particularly useful
for studies of integrin-mediated adhesion because of the wealth of
reagents, such as specific function-blocking monoclonal antibodies.
(For example, the anti- ITGA9 Y9A2 monoclonal antibody does
not label mouse eggs by immunofluorescence [data not shown],
Figure 1. ADAM2 binding to eggs. Eggs were left untreated (no
addition), or treated with the indicated peptide (100 mM; ECD peptide,
corresponding to the ADAM2 disintegrin loop; its negative control ECA;
the ITGA4/ITGA9-blocking peptide MLD, or its control MAA) or 100 mg/
ml of the function-blocking anti-ITGB1 monoclonal antibody Hmb1-1
antibody (anti-b1) or Armenian hamster nonimmune IgG (Nonimm IgG).
Data were normalized to the amount of egg-associated ADAM2 with
the ‘‘no addition’’ controls. Asterisks indicate p,0.05 as compared to
untreated controls and the appropriate control peptide or nonimmune
antibody.
doi:10.1371/journal.pone.0013744.g001
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binding to mouse eggs.)
These studies examined cell adhesion to ADAM2 using cells
expressing the three known members of the ITGA4/ITGA9
family: Tera-2 cells, expressing ITGA9-ITGB1; HT1080 cells,
expressing ITGA4-ITGB1; and RPMI 8866 cells, expressing
ITGA4-ITGB7, and little or no ITGB1 on the cell surface [36,39].
Control experiments showed that cell adhesion levels were very
low with no substrate or a negative control substrate, BSA (,5%
of input cells remaining in the well), that cells adhered well to
positive control substrates (,70–85% of input cells remaining in
the wells with fibronectin or laminin as substrates), and that
chelation of divalent cations abolished cell adhesion (,5% of input
cells adhering to fibronectin, laminin, or ADAM2 in the presence
of 10 mM EDTA), in agreement with what is known about
integrin-mediated adhesion. Tera-2 cells and HT1080 cells
adhered to ADAM2 (Fig. 3A,B), in agreement with other studies
of ITGA4-ITGB1-expressing and ITGA9-ITGB1-expressing cells
[27]. RPMI 8866 cells also adhered to ADAM2 (Fig. 3C).
Adhesion of all three cell types to ADAM2 was inhibited by the
peptide corresponding to the ECD-containing adhesion-mediating
motif in the ADAM2 disintegrin domain, but not by the control
peptide, ECA (Fig. 3).
The involvement of ITGA4/ITGA9 integrins in ADAM2
adhesion was demonstrated through the side-by-side comparisons
of the effects of inhibitory peptides and antibodies, although these
experiments also revealed something unexpected. The ITGA4/
ITGA9-blocking peptide MLD inhibited adhesion of all three cell
types to ADAM2 (Fig. 3). The MLD peptide also effectively
inhibits HT1080 cell adhesion to a known ITGA4-ITGB1 ligand,
the CS-1 (connecting segment 1) region of fibronectin (data not
shown). Adhesion of Tera-2 cells and HT1080 cells to ADAM2
was inhibited by an anti-ITGA9 or anti-ITGA4 function-blocking
antibody respectively; the extent of the antibody-mediated
inhibition was similar to the extent of inhibition observed with
the ECD or MLD peptides (Fig. 3A, B). Surprisingly, the anti-
ITGA4 function-blocking antibody only partially inhibited the
adhesion of RPMI 8866 cells to ADAM2, not as extensive as the
inhibition with the ECD or MLD peptides (Fig. 3C). This differed
from other work showing that RPMI 8866 cell adhesion to various
substrates is inhibited by anti-ITGA4 antibodies; anti-ITGB7
antibodies have similar significant inhibitory effects whereas anti-
ITGB1 antibodies do not affect RPMI 8866 cell adhesion to
numerous substrates, including ADAMs [35,36,39]. Interestingly,
the anti-ITGA9 function-blocking antibody inhibited RPMI 8866
cell adhesion to ADAM2 to a similar partial extent as the anti-
ITGA4 antibody (60% and 67%; Fig. 3C). The combination of
anti-ITGA9 and anti-ITGA4 antibodies inhibited adhesion to a
similar extent as the ECD or MLD peptides (88%), as did an anti-
ITGB7 function-blocking antibody (86%; Fig. 3C).
These data from cell adhesion assays suggested that RPMI 8866
cells adhered to ADAM2 not only through ITGA4-ITGB1 (a4b7)
but also through ITGA9-ITGB7 (a9b7). The surprising finding of
ITGA4- and ITGA9-mediated cell adhesion to ADAM2 prompt-
ed us to examine integrin b subunit expression in RPMI 8866
cells, as ITGA9 has only been reported to dimerize with ITGB1.
RT-PCR demonstrated that RPMI 8866 cells express ITGB1,
ITGB2, ITGB33, ITGB5, ITGB7 and ITGB8 mRNA (Fig. 4A).
Although ITGB1 mRNA was detected, we did not detect ITGB1
protein in immunoprecipitations from lysates of surface-labeled
RPMI 8866 cells (Fig. 4B, lane 3), in agreement with others’
experiments showing little or no ITGB1 surface expression
[35,36,37,38,39]. The anti-ITGB1 antibody was used successfully
in control immunoprecipitations from Tera-2 lysates, as was the
anti-ITGA9 antibody (Fig. 4B; lanes 7–8). The detection of ITGB1
mRNA by RT-PCR suggests that the absence of ITGB1 protein
on the RPMI 8866 cell surface is due to a failure in translation,
trafficking, and/or maintenance/stability. Immunoprecipitations
from RPMI 8866 lysates with an anti-ITGA4 antibody immuno-
precipitated ITGA4 and a b subunit migrating at ,120,000, the
Mr of ITGB7 subunit (Fig. 4B, lane 1), essentially identical to
results obtained with a similar cell line that expresses ITGA4-
ITGB7 and not ITGB1 [45]. The anti-ITGA9 antibody
immunoprecipitated two bands, ITGA9 (Mr= ,142,000) and a
second band at Mr= ,120,000, the same electrophoretic mobility
as the b subunit co-immunoprecipitating with ITGA4, and
differing from the Mr’s of ITGB2, ITGB3, ITGB5, ITGB8,
which are readily distinguishable from ITGB7 as they migrate at a
lower Mr of ,90,000–100,000 [45,46,47,48,49]. Additionally,
immunoprecipitations performed with anti-ITGB7 antibodies
contain a band similar to the size of ITGA9 (Mr= ,142,000)
that cross-reacts with an anti-ITGA9 antibody in immunoblots
(Fig. 4B, lanes 10, 11). Taken together, these data suggest ITGB7
can dimerize with ITGA9 in RPMI 8866 cells.
Since RPMI 8866 cells express Itgb1 mRNA (Fig. 4A), the
possibility remained that low levels of ITGB1 on RPMI 8866 cell
surfaces contribute adhesion to ADAM2. To confirm that RPMI
8866 cells used only ITGB7 integrins to adhere to ADAM2, we
depleted RPMI 8866 cells of ITGB7 by siRNA-mediated
knockdown. The levels of ITGB7 mRNA in RPMI 8866 cells
treated with ITGB7 siRNA were reduced to an average of 23% of
the levels in cells treated with control non-targeting siRNA (n=4
Figure 2. Integrin subunit mRNAs in mouse oocytes. RT-PCR analysis of Itgb subunit and selected Itga subunit expression in mouse oocytes
(Panel A; lanes 1–22) or control tissues (Panel B; spleen, lanes 23–28, 33–34; liver, lanes 29–30). First strand cDNA was prepared from RNA with reverse
transcriptase (+; odd-numbered lanes), or, as a negative control, without RT (2; even-numbered lanes). This shows that oocytes express Itgb1, Itgb3,
Itgb5, Itga1, and Itga8 mRNA. Although Itgb2, Itgb4, Itgb6, Itgb7, Itgb8, and Itgad were not detected in oocytes, these PCR products could be amplified
from control cDNA.
doi:10.1371/journal.pone.0013744.g002
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and 39%). Cells treated with control siRNA or with ITGB7 siRNA
adhered to fibronectin, and cells treated with control siRNA
adhered to ADAM2. Knockdown of ITGB7 reduced adhesion to
ADAM2; ITGB7-knockdown cells had similar levels of adhesion to
ADAM2 and to the negative control substrate (GST), indicating
that the ITGB7 siRNA treatment reduced adhesion to ADAM2 to
baseline levels (Fig. 5). As an additional control, we assessed the
effects of an anti- ITGB7 function-blocking antibody combined
with ITGB7 siRNA treatment (Fig. 5), to determine if residual
levels of ITGB7 protein contribute to adhesion to ADAM2. These
experiments revealed that adhesion to ADAM2 of cells treated
with both ITGB7 siRNA and the FIB27 anti-ITGB7 antibody was
not different from cells treated with treated only with ITGB7
siRNA. On the other hand, adhesion to ADAM2 of control
siRNA-treated cells was inhibited by the FIB27 anti-ITGB7
antibody treatment. These results showed the siRNA-mediated
knockdown in the ITGB7 siRNA-treated cells was effective and
that that there was little or no residual ITGB7 on the surface of
ITGB7 siRNA-treated cells contributing to adhesion to ADAM2.
Discussion
This study had two goals, one specific, one more broad. We
examined if ITGB1 (as the partner to ITGA9) functions as the
primary integrin in mouse eggs that mediates egg interactions with
ADAM2, and characterized the complement of integrin b subunits
in mouse eggs. Second, since eggs in some mammalian species
express other subunits of the ITGA4/ITGA9 family, we examined
the interactions of ITGA4/ITGA9 integrins with ADAM2. This
second set of experiments produced an unexpected result,
indicating the presence of a novel integrin a-b combination in
RPMI 8866 cells that functions as a binding partner for ADAM2.
ITGA9 has only been reported to dimerize with ITGB1, and thus
the ITGA9-ITGB7 heterodimer implicated in RPMI 8866
adhesion to ADAM2 is an unexpected integrin a-b subunit
combination.
The mechanisms that drive integrin subunit dimerization are
only partially characterized [50,51,52]. One factor that appears to
affect integrin heterodimerization is subunit abundance in the cell.
The relative abundance of a particular subunit can affect
dimerization with partner subunits; for example, exogenous
expression of an a subunit presents additional partners to pair
with b subunits, affecting the a-b combinations expressed by a cell
[53,54,55,56,57,58]. In RPMI 8866 cells, the dimerization of both
ITGA4 and ITGA9 with ITGB7 could be facilitated by the
presence/abundance of ITGB7, combined with absence or very
low abundance of ITGB1 (Fig. 4 and [36,39]). In many cell types
(including mouse eggs), ITGB1 is likely to be one of the most, if
not the most, abundant b subunit, favoring ITGB1 dimerization
with available a subunit(s) and likely also minimizing the chance
for a subunits to dimerize with other b subunits besides ITGB1.
Because of the contribution of subunit abundance to subunit
dimerization, ITGA9-ITGB1 is likely to be the main ITGA9
integrin in many cells, including mouse eggs. We expect that
RPMI 8866 cells are reflective of a small subset of cells that express
little or no ITGB1 on the cell surface. Nevertheless, these data
Figure 3. ITGA4/ITGA9-mediated cell adhesion to ADAM2. Cell
adhesion assays were performed with the indicated cell lines (Panel A,
Tera-2 cells; Panel B, HT1080 cells; Panel C, RPMI 8866 cells) with 50 mg/
ml of recombinant ADAM2 as substrate. Cells were left untreated (no
addition), or treated with the indicated peptide (100 mM; ECD peptide,
corresponding to the ADAM2 disintegrin loop; its negative control ECA;
the ITGA4/ITGA9-blocking peptide MLD, or its control MAA) or the
indicated antibody (20 mg/ml; function-blocking anti-ITGA9 monoclonal
antibody Y9A2 [Panels A and C]; the function-blocking anti-ITGA4
monoclonal antibody PS-2 [Panels B and C]; function-blocking anti-
ITGB7 monoclonal antibody FIB27 [Panel C]; or a species-matched
nonimmune IgG). The y-axes indicate the percentage of the input cells
left adherent after washing; errors bars represent the SEM. Asterisks
indicate p,0.05 as compared to untreated controls and the appropriate
control peptide or nonimmune antibody.
doi:10.1371/journal.pone.0013744.g003
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ITGB1.
The data in Figure 2, with other reports of integrin subunit
expression, indicate that mouse eggs express three of eight b
subunits and eight of 18 a subunits (Itgb1, Itgb3, Itgb5, Itga1, Itga2,
Itga3, Itga5, Itga6, Itga8, Itga9, Itgav). Thus, mouse eggs could
express at least ten different integrins, with five in the family of
integrins that bind RGD tripeptide in ligands (e.g., fibronectin,
vitronectin), two in the laminin-binding family, two in the
collagen-binding family, and ITGA9-ITGB1, which can interact
with a variety of ligands (Fig. 6) [1,2]. Several of these integrins,
especially ITGA9-ITGB1, have been shown to interact with
ADAMs [59,60,61]. Itgb7 mRNA was not detected in oocytes, and
the extent of inhibition of ADAM2 binding to eggs by a function-
blocking anti-ITGB1 antibody suggests that ITGB1 integrins are
the major integrins mediating ADAM2-egg interactions. The
other b subunits detected in mouse oocytes are Itgb3 and Itgb5,
although it appears that ITGA9 dimerizes primarily or exclusively
with ITGB1, based on immunoprecipitations of ITGA9 from
mouse egg lysates [10].
The possibility exists, however, that the situation is different in
eggs of other species. ITGA4 is not detected in mouse eggs [10],
but there is evidence for ITGA4 expression in bovine, hamster,
porcine and human eggs, as well as some evidence for ITGB7
expression in human eggs [12,13,14,15]. In a similar vein, Itgb2
mRNA was not detected in mouse eggs, but ITGB2 is detected in
human eggs [15,20,62]. Interestingly, there is some evidence
suggesting that different species’ eggs may rely on different
receptors to varying extents. An anti-ITGA6 function-blocking
monoclonal antibody (GoH3) has been reported to have some [19]
or no [23,63] effect on mouse sperm-egg interactions (even though
this antibody binds to ITGA6 on the mouse egg), but this same
antibody has moderate to significant inhibitory effects on human
sperm-egg interactions [20,64]. Similarly, antibodies to the
tetraspanin CD9 inhibit mouse and pig mouse sperm-egg
interactions [65,66,67], while two different anti-CD9 antibodies
had no effect on human sperm-egg fusion, but partial inhibition is
observed with an antibody to the tetraspanin CD151 [64]. It is
worth considering that species-to-species variation is possible, and
thus the finding here of an ITGA9-ITGB7 heterodimer may be
relevant to fertilization in some species.
The ITGA9-ITGB7 heterodimer raises the question of whether
ITGA9 (or other a subunits) in an Itgb1-deficient cell could
dimerize with unexpected b subunits — a situation roughly
Figure 4. Integrin subunit expression in RPMI 8866 cells. Panel A. RT-PCR analysis of ITGB subunit mRNA expression in RPMI 8866 cells (lanes
1–16) or control tissue (spleen, lanes 17–20). First strand cDNA was prepared from RNA with reverse transcriptase (+), or, as a negative control,
without RT (2). This shows that RPMI 8866 cells express ITGB1, ITGB2, ITGB3, ITGB5, ITGB7, and ITGB8 mRNA. ITGB4 and ITGB6 were not detected in
RPMI 8866 cells, but these PCR products could be amplified from spleen cDNA. Panel B. Lanes 1–6 show immunoprecipitations performed with
lysates from surface-biotinylated RPMI 8866 cells, lanes 7–8 show immunoprecipitations performed with lysates from surface-biotinylated Tera-2 cells,
and lanes 9–11 show immunoprecipitations performed with lysates from unlabeled RPMI 8866 cells; samples were run under non-reducing
conditions. Immunoprecipitations were performed with anti-ITGA4 (lane 1; PS/2), anti-ITGB1 (lanes 3 and 7, ABII2), anti-ITGA9 (lanes 5 and 8, Y9A2),
anti-ITGB7 (lane 10, FIB27; lane 11, FIB504) or appropriate species-matched nonimmune IgGs. Bands in blots with lanes 1–8 were detected with
avidin, and the blot with lanes 9–11were probed by anti-ITGA9 immunoblotting. Open arrowheads indicate integrin a subunits, and solid arrowheads
indicate integrin b subunits (Note: ITGA4 in Lane 1 is observed in intact and cleaved forms [45,94].)
doi:10.1371/journal.pone.0013744.g004
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phenotypically alleviated in multiple ways. Functional compensa-
tion is one, as multiple integrins and other adhesion molecules can
serve as receptors for a given ligand [1,2]; this occurs in some
integrin-deficient cells but not all (e.g., [68,69]). Up-regulation of
compensatory subunits is also possible, although is not detected in
all integrin-deficient cells (e.g., [69,70]). The data presented here
suggest that alternative a-b heterodimerizations could be another
possible compensatory mechanism in certain situations. A
computational study suggests that a-b transmembrane domain
interactions were largely conserved for nearly all a-b combina-
tions, the 24 known combinations as well as the 120 other
combinations [71]. This raises the question of whether the failure
to observe a particular a-b heterodimer is indicative that the a-b
combination cannot form, or that the a-b combination is a rare
occurrence in nature or in the cellular contexts that have been
examined. One proposed explanation for the fact that only certain
a-b combinations have been observed is that that a integrin
subunits may have gained or lost the ability to form heterodimers
with certain b subunits during the course of gene duplication [5].
The originally observed ITGA4/ITGA9 heterodimer combina-
tions could have been viewed as evidence that ITGA4 gained the
ability to dimerize with ITGB7 and/or ITGA9 lost the ability to
dimerize with ITGB7 as Itga4 and Itga9 diverged. However, the
data here provide the insight that both ITGA4 and ITGA9 can
dimerize with ITGB7. Future experiments could shed light on if
this will extend to other subunits. Molecular evolution studies
suggest two families of vertebrate b subunits: the Vertebrate A or
b1 family (Itgb1, Itgb2, Itgb7; Fig. 6, in red) and Vertebrate B or b3
family (Itgb3, Itgb4, Itgb5, Itgb6, and Itgb8; Fig. 6, in blue) [4,5].
ITGAV and ITGA6 dimerize with b subunits in both groups
(Fig. 6); to our knowledge the abilities/inabilities of other a
subunits to dimerize with A/b1 and B/b3 subunits has not been
definitively determined. This will be an interesting area of future
investigation in integrin function and evolution. ITGB1 and
ITGB7 are members of the Vertebrate A/b1 family; it remains to
be determined if ITGA4 and ITGA9 have the ability to dimerize
with Vertebrate B/b3 family members, or only dimerize with
Vertebrate A/b1 family members. There are numerous interesting
future directions for studies of integrin function and a-b
heterodimerization, including focused studies (e.g., RNAi of
ITGA9 in RPMI 8866 cells) and broader research to gain insights
into integrin actions in normal and pathological conditions, and
whether ‘‘compensatory dimerization’’ occurs in other cellular
Figure 5. siRNA-mediated knockdown of ITGB7 mRNA levels
and effects on RPMI 8866 cell adhesion to ADAM2. Panel A:
Sample results from an RT-PCR analysis of ITGB7 siRNA-mediated
knockdown. RNA was isolated from cells transfected with ITGB7 siRNA
(lanes 1, 3) or control siRNA (lanes 2, 4) at 48 hr post-transfection, first-
strand cDNA was prepared, and primers specific for ITGB7 or b-actin
(ACTB) were used in PCR. (The levels of ITGB7 knockdown observed in
four replicate experiments were 100%, 85%, 83, and 39%.) Panel B: Cell
adhesion assays were performed with the substrates plasma fibronectin
(positive control), GST (negative control) or recombinant GST-ADAM2
with RPMI 8866 cells treated with control siRNA (solid bars) or ITGB7
siRNA (open bars). ITGB7-siRNA-treated cells that were to be tested on
GST-ADAM2 were either left untreated (No Ab) or were treated prior to
being added to the wells with 20 mg/ml anti-ITGB7 antibody FIB27, or
nonimmune rat IgG (Non IgG). The y-axes indicate the percentage of
the input cells left adherent after washing; errors bars represent the
SEM. Asterisks indicate p,0.05 as compared to control siRNA-treated
cells.
doi:10.1371/journal.pone.0013744.g005
Figure 6. Heterodimer combinations of a/ITGA and b/ITGB subunits. Diagram is adapted from [1]. The three b subunits that are members of
Vertebrate A branch or b1 family (ITGB1, ITGB2, ITGB7) are shown in red, and members of the Vertebrate B branch or b3 family (ITGB3, ITGB4, ITGB5,
ITGB6, and ITGB8) are shown in blue [4,5]. Ligands that are recognized by certain families of integrins are indicated in ovals. The ITGB2 integrins of
leukocytes are shown to the right. Bolded subunits are detected in mouse oocytes.
doi:10.1371/journal.pone.0013744.g006
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ITGB1 expression.
It is worth noting that there are proteins other than integrins on
eggs and ADAMs on sperm that participate in sperm-egg
membrane interaction [72,73]. Only two, the tetraspanin CD9
on the egg and the immunoglobulin superfamily member
IZUMO1 on the sperm, have been shown in gene knockout
studies to be essential for murine sperm-egg interaction. Other
knockouts have less severe defects or multiple gamete function
defects (e.g., [74]), and mouse eggs deficient in Itga9 or Itgb1 do
differ from wild-type eggs in their ability to support sperm binding
[10,22]. Even though such defects may not translate to a complete
failure of fertilization, these partial loss-of-function defects could be
an underlying cause of subfertility. This may be significant in
humans, considering mice ovulate multiple eggs in short estrus
cycles versus humans ovulating one egg once every ,28 days. A
gamete function deficiency that has only modest effects in the
mouse could produce a more significant effect on human fertility,
particularly since the clinical definition of infertility is an inability
to conceive after a year of unprotected intercourse.
Finally, extending a broader biomedical context, integrins and
ADAMs are involved in numerous processes and disease states –
myoblast fusion, leukocyte homing, cancer, inflammatory diseases,
and respiratory diseases, to name just a few [2,61,75,76,77,78,79]
– making both molecular families of significant interest. The
ITGA4/ITGA9 integrin family interacts with several ADAMs
[27,33,39,80,81]. The work here shows that this integrin family
includes ITGA9-ITGB7, and that this a-b integrin subunit
combination can serve as a binding partner for ADAM2 and
likely other ADAMs as well. Although ITGA9-ITGB7 is not a
widely expressed integrin, the findings presented here nevertheless
suggest that this a-b combination can function as an ADAM
binding partner in certain cellular contexts, providing new avenues
to appreciate the functions of both integrins and ADAMs.
Materials and Methods
Antibodies and peptides
The antibodies used were: anti-ITGB1 monoclonal Armenian
hamster antibody Hmb1-1 [82] (Pharmingen/BD Biosciences);
anti-ITGA4 rat monoclonal antibody PS/2 [83] (Chemicon,
Temecula, CA and Millipore, Billerica, MA); anti-ITGA4 rat
monoclonal antibody R1-2 [84] (Pharmingen/BD Biosciences;
San Diego, CA); anti-ITGA9 mouse monoclonal antibody Y9A2
[85] (Chemicon/Millipore); anti-ITGB1 rat monoclonal antibody
AIIB2 [86] (Developmental Studies Hybridoma Bank, University
of Iowa); anti-ITGB7 rat monoclonal antibody FIB27 [87]
(Pharmingen/BD Biosciences); anti-ITGB7 rat monoclonal anti-
body FIB504 [87] (Santa Cruz Biotechnology, Santa Cruz, CA).
Nonimmune control antibodies used were rat IgG, mouse IgG,
rabbit IgG, and Armenian hamster IgG (Jackson Immunore-
search, Sigma-Aldrich, or BD Biosciences).
Peptides were produced as fusion peptides with bacterial
alkaline phosphatase (BAP-presented peptides) as previously
described [11,24]. The peptide sequence AQDECDVT (hereafter
referred to as ECD) corresponds to the adhesion-mediating
sequence in the ADAM2 disintegrin loop [24,25]; the negative
control for this peptide is AQDECAVT (hereafter referred to as
ECA), and was shown to have minimal effects on ADAM2 binding
to mouse eggs [11,24], in agreement with structure-function
studies of ADAM2 [24,25]. The sequence KRAMLDGLNDY
(hereafter referred to as MLD) corresponds to the disintegrin loop
in the snake venom disintegrin subunits EC3B and EC6A; the
disintegrins EC3 or EC6 or this MLD peptide disrupt adhesion
mediated by ITGA4/ITGA9 integrins [40,41,42]. The negative
control peptide for MLD was KRAMAAGLNDY (hereafter
referred to as MAA). Purified BAP-presented peptides were
extensively dialyzed against culture medium compatible buffer
(109.5 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4,7 m M
NaHCO3, 15 mM HEPES, pH 7.4), and then concentrated to
at least 10 mg/ml (Microcon microconcentrators; Amicon,
Beverly, MA).
Cell lines and culture
RPMI 8866 cells (a human B-cell lymphoblastoid cell line; gift
of Dr. Ron Bowditch, University of Oklahoma, Oklahoma City,
OK; also available from Sigma-Aldrich, St. Louis, MO) were
grown in suspension in RPMI 1640 medium (Mediatech; Herden,
VA), supplemented with 10% fetal bovine serum (FBS), 10 mM
HEPES (Mediatech), 1 mM sodium pyruvate (Mediatech), 1 mM
L-glutamine (Mediatech) and 50 mg/ml gentamicin (Cellgro,
Herden, VA). Cells were cultured in a humidified incubator with
5% CO2 in air at 37uC and routinely split at the ratio of 1:5 by
diluting the cell suspension with the appropriate medium. Tera-2
cells (a human teratocarcinoma cell line; American Type Culture
Collection, Manassas, VA) and HT1080 cells (a human fibrosar-
coma cell line; American Type Culture Collection) were
maintained as adherent cells in Dulbecco’s Modified Eagle’s
medium (DMEM; Mediatech) supplemented with 10% fetal
bovine serum (Sigma) and 50 mg/ml gentamicin. These cells were
cultured in a humidified incubator with 5% CO2 in air at 37uC,
and split when they neared confluency.
Assays of ADAM2 interaction with cells
Recombinant mouse ADAM2 (fertilin b) disintegrin domain
was generated as a fusion protein with glutathione S-transferase
(GST) as previously described [11]. ADAM2 was cleaved from
GST as previously described [11], or left intact as GST-ADAM2,
with GST included as a negative control.
The binding of ADAM2 to zona pellucida (ZP)-free eggs was
assessed as previously described [11]. In brief, ovulated mature,
metaphase II eggs were collected from 6–8 week-old superovulated
CF-1 mice (Harlan, Indianapolis, IN) at ,13 hours after human
chorionic gonadotropin injection, and cumulus cell and ZP
removal was performed as previously described [10,11]. ZP-free
eggs were incubated in Whitten’s medium containing 100 mM
ECD, ECA, MLD or MAA peptides [11], or 100 mg/ml of anti-
ITGB1 Hmb1-1 antibody or 100 mg/ml nonimmune Armenian
hamster IgG [10] for 60 min. The eggs were then incubated with
0.5 mg/ml recombinant ADAM2 in the presence of the indicated
peptide or antibody for an additional 60 min. Egg-associated
ADAM2 was measured using a luminometric immunoassay as
previously described [11]. All work involving animals was
conducted with approval from the Johns Hopkins University
Animal Care and Use Committee.
Cell adhesion assays followed established protocols [88].
Immulon-2 HB 96-well plates (Dynatech Laboratories, Chantilly,
CA) were coated with 75 ml of ADAM2 at 4uC overnight.
Preliminary experiments of adhesion to ADAM2 using 25–
200 mg/ml per well revealed that maximal adhesion was observed
with 50 mg/ml, with similar levels of adhesion in wells coated with
100 or 200 mg/ml (X. Zhu, Ph.D. dissertation); studies here used
ADAM2 and GST at 50 or 100 mg/ml. Prior to the adhesion
assay, each well was blocked with 1% heat-inactivated (15 min,
80uC) BSA (Fraction V, Sigma) at 37uC for 1 hr. RPMI 8866 cells
grown in suspension were collected by centrifugation at 10006g
for 5 min at room temperature, washed twice with serum-free
RPMI 1640 or DMEM medium and resuspended to a
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6 cells/ml. For preparation of Tera-2 cells and
HT1080 cells for adhesion assays, cells were detached by
treatment with 0.025% trypsin-EDTA (Gibco, Invitrogen, Grand
Island, NY), and washed twice in serum-free DMEM, then
resuspended to a concentration of 10
6 cells/ml in DMEM. In
experiments in which the effects of anti-integrin antibodies or
inhibitory peptides were examined, the detached cells were
incubated with the indicated antibody (25–50 mg/ml as noted)
or peptide (100 mM) for 30 min at 37uC prior to use in the
adhesion assay. For the adhesion assay, 100 ml (10
5 cells) were
added to each well; cells were then cultured at 37uC for 1 hr.
Following this incubation, unbound cells were washed off by
rinsing each well three times with PBS (137 mM NaCl, 3 mM
KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4). Adherent
cells were fixed with 5% gluteraldehyde (Sigma) in PBS for 1 hr at
room temperature and then stained with 0.1% crystal violet
(Sigma) in PBS for 1 hr at room temperature. The fixed and
stained cells were solubilized with 10% acetic acid in H2O for
30 min in room temperature. The optimal density of each well at
575 nm (OD575) was then read with a microplate reader
(Molecular Device Corp, Sunnyvale, CA).
Isolation of total RNA and reverse transcription (RT)-PCR
Oocyte RNA was prepared as previously described [10]. RNA
was isolated from ,10
7 cultured cells or from mouse tissues
(,0.75 cm
3 piece of mouse spleen or liver) with Trizol reagent
(Invitrogen, Carlsbad, CA) according to manufacturer’s instruc-
tions. First strand cDNA was synthesized from 1–5 mg total RNA
with random primers using SuperScript Reverse Transcriptase III
(Invitrogen) according to the manufacturer’s recommendations.
Primers used for PCR are shown in Table 1; primers match both
human and mouse integrin subunits. PCR was conducted using
Taq polymerase (New England BioLabs, Ipswich, MA) and a
Thermo Electron Corporation Px2 Thermal Cycler (Milford,
MA). PCR products were separated on a 1% agarose gel and were
visualized under UV light after staining with ethidium bromide.
Cell surface biotinylation, immunoprecipitation and
immunoblotting
About 1–3610
7 cells were collected from one T-75 cm
2 tissue
culture flask (BD Falcon; Franklin Lakes, NJ), pelleted by
centrifugation at 15006 g for 5 min and washed twice with
PBS. The pelleted cells were resuspended in 1 ml serum-free
medium (DMEM or RPMI 1640) containing 0.5 mg/ml EZ-link
sulfo-LC-biotin (Pierce Chemical Company, Rockford, IL) and
incubated at 37uC for 30 minutes with constant rotation. The
reaction was quenched with by adding 10 ml of 1 M Tris-HCl
(pH 7.5), after which the cells were pelleted and washed with PBS
to remove the remaining free biotin. The surface-biotinylated cells
were lysed in 500 ml lysis buffer (50 mM Tris-HCl, pH 7.4,
150 mM NaCl, 2 mM CaCl2 and 1% Triton-X-100) supplement-
ed with 1 mg/ml leupeptin, 1 mg/ml aprotinin and 1 mM
AESBF (Sigma) for 30 minutes on ice, followed by centrifugation
at 14,0006g for 15 min at 4uC. Total protein concentration of the
resulting lysate was determined by BCA Microassay kit (Pierce).
For immunoprecipitations, cell lysates were first pre-cleared by
adding 40 ml Protein G-Sepharose beads (Upstate, Lake Placid,
NY) to the lysate (,40 mg total protein) and mixed at 4uC
overnight. The precleared lysates were then combined with 1 mg
of the appropriate anti-integrin antibody or nonimmune IgGs and
incubated at 4uC for 4 hr with constant rotation. The antigen-
antibody complexes were captured onto 20 ml Protein G beads by
tumbling at 4uC overnight. The Protein G-Sepharose beads bound
with integrin-antibody complexes were washed five times with ice-
cold lysis buffer at 4uC. Following washing, the beads were
resuspended in SDS-PAGE sample buffer (2% SDS, 5.5% sucrose,
0.006% bromophenol blue, 80 mM Tris-HCl, pH 6.8), heated at
100uC for 5 min; protein samples were separated on a 7% non-
reducing SDS-PAGE gel, then transferred to an Immobilon-P
membrane (Millipore, Billerica, MA). Biotinylated proteins were
detected with ImmunoPure ABC Peroxidase Staining Kit (Pierce).
For Figure 3, lanes 9–11, immunoprecipitations were performed
using nonimmune or anti-ITGB7 antibodies, and detection was
performed with an anti-ITGA9 polyclonal antibody [89].
Although there is a report that this anti-ITGA9 antibody showed
cross-reactivity in immunoblots of rat tissues, particularly with a
Mr= ,100,000 band [90], this anti-ITGA9 antibody has not
shown such cross-reactivity in immunoprecipitations from mouse
or human lysates [89,91,92,93]. The band that we detect here is
Mr= ,142,000, in agreement with the expected electrophoretic
mobility of ITGA9.
siRNA-mediated knockdown of ITGB7 in RPMI 8866 cells
siRNA studies used ON-TARGETplus Duplex J-008013-06-
0020 corresponding to human ITGB7 with sense sequence 59
CCACAUUUCUUACGAAUCCUU 39 and antisense sequence
59 PGGAUUCGUAAGAAAUGUGGUU, and ON-TARGET-
plus siCONTROL non-targeting siRNA served as a negative
control (Dharmacon, Lafayette, CO). RPMI 8866 cells were
transfected with ITGB7 or control siRNA according to the
manufacturer’s protocol. Briefly, 10
7 cells were suspended in
400 ml serum-free RPMI 1640 medium containing 1 mM ITGB7
or control siRNA and 8 mg pMACS K
k.II plasmid (Miltenyi Biotec
Inc., Auburn, CA) in an electroporation cuvette (BTX, 2 mm gap,
Holliston, MA) and incubated in room temperature for 10
minutes. Cells were then electroporated at 270 V, 5 pulses,
10 msec each (BTX ECMH 830 electroporator, San Diego, CA)
and immediately placed in a humidified incubator with 5% CO2
in air at 37uC for 10 minutes. Cells were then transferred into a T-
75 cm
2 tissue culture flask (Falcon) containing 10 ml pre-warmed
10% fetal bovine serum-supplemented culture medium and
Table 1. Primers used for PCRof mouse and human integrin
subunits.
Target Forward (59-39) Reverse (59-39)
Itgb1 (b1) GAGGTTCAATTTGAAATTAGC GGCTCTGCACTGAACACATTC
Itgb2 (b2) CTACTCCATGCTTGATGACC TTCTCCTTCTCAAAGCGCCT
Itgb3 (b3) GGACATCTACTACTTGATGG ACCGTGTCTCCAATCTTGAG
Itgb4 (b4) CCTCATGGACTTCTCCAACT GGGACACTGGAAGTTGTCAT
Itgb5 (b5) TATGCACTAGTGGAAGTGCC CCCTCACACTTCCTCTGACC
Itgb6 (b6) TCTGACATTGTTCAGATTGC ACTTCCAGTTCCACCTCAGA
Itgb7 (b7) CAGCTCATCATGGATGCTTA GAAGAAGAACAGCTGGTTGTC
Itgb8 (b8) GGATGGTGTGTTCAAGAGGA GATTCTATTTCACCAGCAATGG
Itga1 (a1) GGATCAACTTTAGTCACCAA TGTGAATAATGAGCACTGAA
Itga8 (a8) GCCCAGCTTCTGCTGCACCG CCCAAGGTCACACACCACCA
Itgad (aD) TGGATCTCGACTCGTGGTGG CACTTTTTCGGGCCCCATTC
Actb
(b-actin)
CCAACTGGGACGACATGGAG CCTGCTTGCTGATCCACATC
doi:10.1371/journal.pone.0013744.t001
ITGA9-ITGB7 (a9b7) Binds ADAM2
PLoS ONE | www.plosone.org 8 October 2010 | Volume 5 | Issue 10 | e13744cultured for 48 hr. pMACS K
k.II-transfected cells were enriched
using a magnetic bead-tagged antibody to human H2Kk and a
MACS apparatus (Miltenyi Biotec Inc.) according to the
manufacturer’s specifications. For cell adhesion assays, cells were
eluted from MACS
 MS Separation column in serum-free RPMI
1640 medium. For assessment of RNA knockdown, RNA was
isolated from ,10
6 cells transfected with either ITBG7 or control
siRNA. First strand cDNA was synthesized from 5 mg total RNA
using random primers and SuperScript Reverse Transcriptase III
(Invitrogen) according to the manufacturer’s protocol. PCR
primers for ITGB7 and b-actin (ACTB) (Integrated DNA
Technologies or Invitrogen) are shown in Table 1. For each set
of primers, the linear range in semi-log plots of the amount of PCR
product as a function of cycle number was determined; the cycle
number used for each primer pair was in this linear range. After
PCR, the products were separated and visualized with UV light as
described above. The signal intensities of the bands were
quantified using Quantity One version 4.4.1 software (Bio-Rad
Laboratories, Hercules, CA). The ITGB7 signal was expressed as a
ratio to the signal intensity of the control ACTB bands.
Statistical Analysis
Statistical analyses were performed by ANOVA with Fisher’s
protected least significance difference post-hoc testing, performed
with StatView version 5.5 (SAS Institute, Cary, NC).
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